Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (Parenthetical) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 9 Months Ended |
---|---|---|
Sep. 30, 2012
|
Sep. 30, 2012
|
|
Interest rate on Convertible note | 5.00% | 5.00% |
Tax expense on the derecongnition of equity component of 5.0% convertible notes | $ 662 | |
Tax benefit on fair value of interest rate swap agreements | 50 | |
Dividends per share | $ 0.025 | $ 0.075 |
Paid-In Capital
|
||
Interest rate on Convertible note | 5.00% | 5.00% |
Tax expense on the derecongnition of equity component of 5.0% convertible notes | 662 | |
Retained Earnings/ (Accumulated Deficit)
|
||
Dividends per share | $ 0.075 | |
Accumulated Other Comprehensive Income (Loss)
|
||
Tax benefit on fair value of interest rate swap agreements | $ 50 |
X | ||||||||||
- Definition
Tax effect of adjustments to additional paid in capital equity component of convertible debt subsequent adjustments. No definition available.
|
X | ||||||||||
- Definition
Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Interest rate stated in the contractual debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Tax effect, net of reclassification adjustments, of the change in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Also includes an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|